AUNA S.A. Stock Price, News & Analysis

Auna (NYSE/BVL:AUNA), a leading healthcare services provider in Latin America, has initiated trading of its common shares on the Lima Stock Exchange (BVL), marking a significant expansion of its market presence. The company, which operates in Mexico, Peru, and Colombia, becomes the only healthcare company listed on the BVL.

This dual-listing strategy aims to enhance trading liquidity, strengthen Auna's presence in Latin American capital markets, and broaden access for local and regional investors. The company's shares will continue trading on both the NYSE and BVL under the ticker symbol "AUNA", potentially increasing its eligibility for inclusion in various equity indices and expanding its institutional investor base.

Auna (NYSE:AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru, and Colombia, has scheduled its Second Quarter 2025 financial results announcement.

The company will release its earnings on Tuesday, August 19, 2025 after market close, followed by a conference call on Wednesday, August 20, 2025 at 8:00 a.m. ET. A quiet period will be observed from August 4 through August 19, 2025.

Auna (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru, and Colombia, announced that its controlling shareholder Enfoca has successfully refinanced its sponsor-level financing. The new facility extends the maturity date from October 5, 2025, to the end of June 2027, and includes improved economic terms for sponsors and pre-IPO shareholders.

Importantly, Auna is not a party to, does not guarantee, and has no liability regarding the debt under this new sponsor-level financing. The refinancing is expected to strengthen the long-term alignment between Auna and its pre-IPO shareholders while supporting the company's strategic growth initiatives in Spanish-speaking Latin America.

Auna (NYSE: AUNA), a Latin American healthcare platform, reported mixed Q1 2025 financial results. Consolidated Revenue decreased 3% YoY to S/1,042 million (though up 4% FXN), while Adjusted EBITDA fell 8% YoY to S/222 million (up 1% FXN). The company's Adjusted EBITDA Margin decreased 1.1p.p. to 21.4%. Adjusted Net Income improved to S/55 million from S/22 million in 1Q24. Peru showed strong performance, while Mexico faced challenges with market softness and operational setbacks. Colombia's results were impacted by provisions but showed encouraging signs in cash flow management. The company maintained a stable Leverage Ratio of 3.6x, improved from 4.3x in 1Q24. Currency depreciation significantly impacted results, with MXN/PEN down 22% and COP/PEN down 9%.

Auna (NYSE: AUNA), a Latin American healthcare company, has announced the pricing of $62.1 million in additional 10.000% senior secured notes due 2029. These Additional Notes will be issued under the same indenture as the company's existing $310.8 million notes issued in December 2023. The offering is private, targeting qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S. The Additional Notes will be guaranteed on a senior secured basis by certain Auna subsidiaries. The proceeds will be used to partially prepay debt under a November 2023 credit agreement and cover related expenses.

Auna (NYSE: AUNA), a Latin American healthcare company, announced a private offering of additional 10.000% senior secured notes due 2029. The Additional Notes will be offered to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S. These notes will supplement the existing US$ 310.8 million of 10.000% senior secured notes previously issued in December 2023. The Additional Notes will be guaranteed on a senior secured basis by certain Company subsidiaries. Proceeds will be used to partially prepay indebtedness under a November 2023 credit agreement and cover related expenses. The final terms and pricing will depend on market conditions.

Auna (NYSE: AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru and Colombia, has scheduled its First Quarter 2025 financial results announcement. The company will release its earnings after market close on Tuesday, May 20, 2025, followed by a conference call on Wednesday, May 21, 2025 at 8:00 a.m. ET.

A quiet period will be observed from Monday, April 28 through Tuesday, May 20, 2025. Interested parties can participate in the conference call via telephone using the toll-free number +1 888 596 4144 or international number +1 646 968 2525 with entry passcode 3884034.

Auna S.A. (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru and Colombia, has announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024. The report was filed with the Securities and Exchange Commission (SEC) on April 10, 2025.

The Annual Report can be accessed through the SEC's website or the 'Financial Info' section of Auna's Investor Relations website. Shareholders can also request a free hard copy of the company's audited financial statements or complete 2024 Form 20-F by contacting the Investor Relations team.

Auna (NYSE: AUNA), a Latin American healthcare platform, reported strong financial results for Q4 and FY 2024. Fourth quarter highlights include:

• Revenue up 4% YoY to S/1,063 million (+11% FXN)
• Adjusted EBITDA increased 19% YoY to S/254 million (+28% FXN)
• Adjusted EBITDA margin expanded 3.1 p.p. to 23.9%
• Net Income improved to S/24 million from a loss of S/219 million in 4Q23

Full-year 2024 performance showed:

• Revenue growth of 13% YoY to S/4,386 million
• Adjusted EBITDA rose 20% YoY to S/993 million
• Net Income of S/124 million, compared to a loss of S/214 million in 2023
• Leverage ratio improved to 3.6x from 4.5x in 4Q23

The company faced challenges in Colombia with certain payors but showed strong momentum in Mexico and Peru. Auna maintains its internal guideline of 20% FXN Adjusted EBITDA growth annually, though 2025 performance will depend on Colombian operations.